6 Reksa Dana Terbaik dengan RVMD.W / Revolution Medicines, Inc. - Equity Warrant (NasdaqGS)

Revolution Medicines, Inc. - Equity Warrant

US ˙ NasdaqGS

HINDI NA ACTIVE ANG SIMBONG ITO

6 Reksa Dana Terbaik dengan RVMD.W / Revolution Medicines, Inc. - Equity Warrant

Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di RVMD.W / Revolution Medicines, Inc. - Equity Warrant. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel. .

Tanggal File	Sumber	Investor		Ketik	Presyo ng Avg (Silangan)	Saham	Δ Saham (%)	Dilaporkan Nilai ($1000)	Nilai Δ (%)	Alokasi Port (%)
2025-08-25	NP	MMBUX - MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund Class I				1,166	0.00	0
2025-07-22	NP	DMSFX - Destinations Multi Strategy Alternatives Fund Class I				88,320	0.00	9	28.57
2025-08-26	NP	PRHSX - T. Rowe Price Health Sciences Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				198,505	0.00	54	657.14
2025-08-26	NP	PRNHX - T. Rowe Price New Horizons Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				302,672	0.00	82	636.36
2025-06-25	NP	TMSRX - T. Rowe Price Multi-Strategy Total Return Fund This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				2,200	0.00	0
2025-08-29	NP	JAFMX - Health Sciences Trust NAV				4,502	0.00	1

Other Listings

US:RVMDW

US$ 0.20

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.